Sofinnova Ventures »

Rapport Therapeutics shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-09-30 $41M 2.0M 20.48
2024-06-30 $45M 2.0M 23.26

More positions owned by Sofinnova Ventures

Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Novo-Nordisk A S Adr (NVO)
AstraZeneca Sponsored Adr (AZN)
Ideaya Biosciences (IDYA)
Elanco Animal Health (ELAN)
Bioage Labs
Axsome Therapeutics Put Option (AXSM)
Incyte Corporation (INCY)
Soleno Therapeutics (SLNO)
Rapport Therapeutics (RAPP)
Arrivent Biopharma (AVBP)
Y Mabs Therapeutics (YMAB)
Dyne Therapeutics (DYN)
Cogent Biosciences (COGT)

View all positions for Sofinnova Ventures

Top funds holding Rapport Therapeutics

Arch Venture Corp
Cormorant Asset Management
Capital Research and Management Company - Division 3
Johnson & Johnson
Sofinnova Ventures
T. Rowe Price Investment Management
Alliancebernstein
T. Rowe Price Associates
Perceptive Advisors
BlackRock
Citadel Advisors
Siren
Logos Global Management
Geode Capital Management
Woodline Partners

View all funds holding Rapport Therapeutics